See also this year's filing and all EDGAR filings for this company.
PDF Report 0001587221_2022_Zosano_Pharma_Corp.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001587221, Zosano Pharma Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,609,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 32,557,000 |
| 3 | remainder_Assets | 4,224,000 |
| 4 | LiabilitiesCurrent | 11,133,000 |
| 5 | LiabilitiesNoncurrent | 3,312,000 |
| 6 | remainder_Liabilities | 970,000 |
| 7 | CostOfGoodsAndServicesSold | 3,920,999 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,412,150 |
| 9 | ResearchAndDevelopmentExpense | 20,993,753 |
| 10 | remainder_Expenses | 195,081 |
| 11 | remainder_Revenues | 856,142 |
| 12 | remainder_NetIncome | 1,424,157 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 48,390,000 |
| 1 | Liabilities | 15,415,000 |
| 2 | Expenses | 35,521,983 |
| 3 | Revenues | 856,142 |
| 4 | StockholdersEquity | 32,975,000 |
| 5 | NetIncome | -33,241,684 |
| 6 | ComprehensiveNetIncome | -33,241,684 |
| 7 | BaseVar | 50,803,641 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.21 |
| 9 | EconomicCapitalRatio | 2.47 |
Edgar->Model Mapping
Feature Distribution
Change over Time
